1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Joint Instability: new trials by email Literature Review of Joint Instability trials Research Report on Joint Instability
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Regenerative Medicine for Joint Hypermobility and Instability Dextrose 20% Prolotherapy, Autologous Platelet-Rich Plasma, Doxycycline Hyclate Injectable (Investigational) - Ehlers-Danlos Syndrome Hypermobility Type (hEDS), Ehlers-Danlos Syndrome (EDS) | Phase 1 / Phase 2 | Not yet recruiting | Manhattan Pain Medicine, PLLC | 100 | 2027-01-15 | 2026-10-06 |
Ehlers-Danlos Syndrome (1) · Ehlers-Danlos syndrome type 3 (1) · Joint Dislocations (1) · Musculoskeletal Pain (1) · Sprains and Strains (1)
Cardiovascular Diseases (1) · Collagen Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Joint Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Neurologic Manifestations (1) · Pain (1)
Glucose (1) · Prolotherapy (1)
Manhattan Pain Medicine, PLLC (1)
Jason Siefferman, MD (1) · Mariia Safroshkina, MD (1)